Biozeen appoints new President and CEO
Mahadevan most recently served as the Global Director and Commercial leader with Merck Millipore where he led global market segment strategic initiatives. He brings to board over twenty four years of strong understanding of Healthcare and Life Sciences sector.
Dr. Anil Paul Kariath speaking on behalf of the Board of Directors, BiOZEEN expressed his delight on having the versatile leader by stating, ’BiOZEEN identified in Mahadevan a dynamic leader with clarity on visionary and operational skills, both from technology and geography perspective, making him the right match for us.’ He further added that, ’In the past Mr. Mahadevan has executed global strategies with his industry knowledge, strong networking skills and industrial contacts. I believe this will help him steer Biozeen to the next level.’
Mahadevan cites several opportunities for the industry and organization, ’Life Sciences and emerging markets is where the next wave of biotech growth is poised to occur. As a total solutions provider our business model integrates Consulting, Design & Build Equipments and training that would insure productivity and facilitate growth in the bio-pharmaceutical industry as we at BiOZEEN plan to be their unique partner.’
No comments posted yet. Be the first to post a comment
Please enter your name
Please enter your comment
Your comment submitted successfully.Please wait for admin approval.
Some error on your process.Please try one more time.
Membership of the EU is damaging the British farming industry, according to...
BASIS has launched an accreditation for pilots of Unmanned Aerial Systems (...
UK wheat yields have theoretical potential to more than double over the nex...
Britain’s farmers flocked to Peterborough for the first day of LAMMA’15 to ...
The crisis in the dairy industry is not the fault of supermarkets, accordin...
Transport Minister Baroness Kramer visited three rural businesses in Cheshi...
Spearheading the John Deere range of mid-size tractors from Mannheim, the n...
Regular testing for bovine TB could significantly reduce the number of infe...
Single-issue policy-making threatens to hamper, not help, the progress of U...